Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 1;100(2):170-173.
doi: 10.1097/OPX.0000000000001988. Epub 2023 Jan 13.

Case Report: Acquired Brown Syndrome after COVID-19 Vaccination

Affiliations
Case Reports

Case Report: Acquired Brown Syndrome after COVID-19 Vaccination

Alaa E Fayed et al. Optom Vis Sci. .

Abstract

Significance: Brown syndrome, or superior oblique tendon sheath syndrome, is characterized by limitation of elevation on adduction. The disorder is thought to involve the trochlea/superior oblique tendon complex through traumatic, surgical, and inflammatory mechanisms. It could be an indication of multiple underlying immunological or rheumatological disorders.

Purpose: This study aimed to report an unusual strabismus after receiving the first dose of a live attenuated coronavirus disease 2019 (COVID-19) vaccine.

Case report: A 31-year-old female patient presented with painful vertical diplopia and tenderness of the left trochlear area 3 days after the first dose of COVID-19 vaccination. She had a compensatory chin elevation and face turn to the right, as well as a left 10-prism-diopter hypotropia in the primary position, which increased to 15 prism diopters in the right gaze and disappeared in the left gaze. Ocular motility revealed the limitation of elevation on adduction. The patient denied any history of ocular trauma and was consequently investigated for dysthyroid disease and various immunological and rheumatological disorders, which were excluded. A Hess chart was obtained to document the motility disorder.

Conclusions: We report a case of acquired Brown syndrome in a 31-year-old otherwise healthy woman shortly after COVID-19 vaccination. It is possible that the patient may have developed trochleitis and/or superior oblique tenosynovitis brought on by cross-reacting antibodies generated by the immune response to the vaccine. In the age of the widest vaccination campaign in human history, it is highly likely that we will continue to observe many unexpected potential adverse effects of these vaccines in our clinical practice.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.

Figures

FIGURE 1
FIGURE 1
Clinical timeline of the case. A 31-year-old woman presenting with acquired Brown syndrome after AstraZeneca COVID-19 vaccination and treated with oral steroids. COVID-19 = coronavirus disease 2019; CT = computed tomography.
FIGURE 2
FIGURE 2
Hess chart demonstrating left Brown syndrome and resolution after treatment with oral corticosteroids. Top row: Hess chart showing hypotropia of the left eye with an abnormal superior part of the left field. There is clear evidence of left inferior oblique underaction and right superior rectus overaction, consistent with left Brown syndrome due to a tight superior oblique. Bottom row: Hess chart repeated 8 weeks after beginning treatment with corticosteroids showing that both eyes were orthophoric in the primary position with no limitation of ocular motility in any direction.
None

References

    1. Wilson ME, Eustis HS, Jr., Parks MM. Brown's Syndrome. Surv Ophthalmol 1989;34:153–72. - PubMed
    1. Fard MA, Kasaei A, Abdollahbeiki H. Acquired Brown Syndrome: Report of Two Cases. J AAPOS 2011;15:398–400. - PubMed
    1. Gutmark R, Eliasieh K, Rivera-Michlig R. A Case of Bilateral Trochleitis in Adult-onset Still's Disease. Semin Arthritis Rheum 2014;43:689–91. - PubMed
    1. Chen X Laurent S Onur OA, et al. A Systematic Review of Neurological Symptoms and Complications of COVID-19. J Neurol 2021;268:392–402. - PMC - PubMed
    1. Ortiz-Seller A Martínez Costa L Hernández-Pons A, et al. Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm 2020;28:1285–9. - PubMed

Publication types

Substances